Team

Stan Barta was diagnosed with Hodgkin Lymphoma at age 13, fifty years ago. Five years of surgery, Cobalt radiation, and MOPP chemotherapy lead him to complete remission, just in time for high school graduation.

This was followed by 30 years of good health, travel adventures, sailing, and boat-building. When Stan and his wife Cathi adopted two toddler boys from Thailand, they moved the whole family to their tug/trawler, where Stan became the “at home parent,” home-schooling his sons aboard ship. The family had numerous maritime escapades in the coastal waters of Washington and British Columbia.

Stan began to experience late effects about ten years ago. He credits Dr. Michael Stubblefiled’s vigilance with preventing him from having a fatal heart attack. Stan was diagnosed with “advanced radiation-induced coronoary artery disease” (CAD), heart failure with preserved ejection fraction (HFpEF), and cardiac cachexia.

Stan used to lament the things he can no longer do, due to fatigue and shortness of breath. With the help of a palliative care therapist, he has turned to exploring what he CAN be, and what his true values are.

Many will remember Stan’s wonderful talk on Dr. Thomas Hodgkin, presented via Zoom last year. If you missed it, you can watch it here via our Hodgkin’s International YouTube channel.

Anastasia was diagnosed with stage 2B Bulky HL at the age of 24 in 2009 and treated with ABVD. After a battle with Bleomycin Toxicity that left doctors divided on whether consolidative radiation should be used, Anastasia opted for Proton Therapy, enrolling in a research study and becoming the first patient to receive her treatment in all protons at the University of Florida Proton Therapy Institute.

Today, Anastasia works as a Real Estate Broker and is a self-published author. She is happily married with two daughters ages 7 and 10. She is passionate about Hodgkin’s advocacy, sobriety, and thanking God for every experience.

Anastasia has already made significant contributions to the survivorship world and to our organization in particular. She has been instrumental in creating our TikTok site and has populated it with educational and inspiring posts. As a younger survivor, Anastasia’s voice and experience is crucial in understanding the needs of ALL Hodgkin’s survivors.

After receiving her degree in nursing from the University of Arizona in Tucson in 1969, Susan Leigh served as a Lieutenant in the U.S. Army Nurse Corps. Seven months after completing a tour of duty in the Mekong Delta in South Vietnam, she was diagnosed with Hodgkin lymphoma and treated with some of the earliest forms of chemotherapy and radiation. This experience influenced her decision to enter the newly founded field of oncology nursing and began this phase of her career working as a research nurse in the new Department of Hematology/Oncology at the University of Arizona Medical Center.

For the past 35 years, Susan has focused her efforts on national advocacy work with special emphasis on the long-term and late effects of cancer treatment. Her most cherished involvement has been with the National Coalition for Cancer Survivorship (NCCS) as a founding member and past president. She has also been actively involved with many professional organizations, including the Oncology Nursing Society and the National Cancer Institute.

Susan also worked as a Survivorship consultant and educator with Arizona Oncology, a multi-site community practice in Tucson, until multiple treatment-related cardiac complications made it difficult to fulfill work obligations and accelerated her decision to retire.

Dr. Sholi is the regional director for UPMC Hillman cancer center in north-central Pennsylvania. He is a graduate of the University of Jordan medical school and did his residency in Internal medicine at a Temple University community program, the Scranton Temple Residency Program.

He completed his hematology and oncology fellowship at the Medical College of Wisconsin in Milwaukee, Wisconsin, in 2003. Dr. Sholi practiced hematology and oncology in private practice and in hospital-based practice and finally joined UPMC Hillman cancer center in 2019.

He is also a survivor of Hodgkin lymphoma.

Dr. Sholi was diagnosed in 1989 with stage IIB Hodgkin’s lymphoma and received chemotherapy and radiation treatment at the Royal Marsden cancer center in Surrey , England.

He looks forward to sharing his personal story, from diagnosis, through treatment and completing medical school as well as post graduate training and how it shaped his life as an Oncologist. He would like also to discuss long term complications of treatments of Hodgkin lymphoma and how to cope with that risk.

Dr. Kevin Oeffinger is a family physician, the founding Director of the Duke Cancer Institute (DCI) Center for Onco-Primary Care, the Director of the DCI Cancer Supportive Care and Survivorship Center, and Professor of Medicine with Tenure in the Division of Medical Oncology in the Department of Medicine. The four-fold mission of the Center for Onco-Primary Care are to: (1) deliver evidence-based, patient-centered health care across the cancer continuum by enhancing the interface between cancer specialists and primary care clinicians; (2) conduct innovative research with cutting-edge technology that can be translated to the community setting; (3) train and educate clinicians and researchers to extend this mission; and (4) generate policy leading to practice redesign.
Dr. Oeffinger has served as a clinician caring for Hodgkin lymphoma survivors for over 30 years. He has also led several studies supported by the National Cancer Institute aimed at improving the long-term health of Hodgkin lymphoma survivors.

Emily S. Tonorezos, MD, MPH, serves as director of the Office of Cancer Survivorship, part of the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). In this position, Dr. Tonorezos leads NCI’s efforts to address the challenges facing cancer survivors and their families – to prevent or mitigate adverse effects and to improve the health and well-being of cancer survivors from the time of diagnosis through the remainder of their lives.

Dr. Tonorezos came to NCI from Memorial Sloan Kettering Cancer Center and the Weill Cornell Medical College, both in New York, NY, where she served as director of the Adult Long-Term Follow-Up Program for survivors of childhood and young adult cancers. Her research, which has been funded by the National Cancer Institute, the American Cancer Society, the American Institute of Cancer Research, and others, focuses on cardiometabolic consequences of cancer therapy, childhood and young adult cancer survivorship, diet and nutrition, and care coordination for this population. She serves as Obesity and Diabetes Mellitus Silo leader for the Children’s Oncology Group (COG) Long-Term Follow-Up Guidelines and as co-leader of the International Guideline Harmonization Group for the metabolic syndrome. She also has served on the National Academy of Sciences, Engineering and Medicine Committee on Childhood Cancer and Disability and on the Cancer Survivorship Committee, the Adolescent and Young Adult Task Force, and the Clinical Guideline Committee for the American Society of Clinical Oncology (ASCO). In addition, Dr. Tonorezos led a recent international effort to develop recommendations for adult survivors of heritable retinoblastoma.

Dr. Tonorezos earned her medical degree from the University of Rochester School of Medicine and a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health. She completed internal medicine residency and chief residency at Columbia University Medical Center, as well as a general internal medicine fellowship at the Johns Hopkins Hospital.

Shelley Fuld Nasso, MPP, is CEO of the National Coalition for Cancer Survivorship, where she advocates to transform the cancer care system for everyone touched by cancer. NCCS engages in public policy efforts to improve cancer care and empowers cancer survivors and caregivers to be a voice in public policy debates. Prior to joining NCCS in 2013, she led public policy efforts at Susan G. Komen. She is a graduate of Rice University and the Harvard Kennedy School. She advocates in honor of her dear friend, Dr. Brent Whitworth, a beloved physician who died of cancer at the age of 43.

After receiving her degree in nursing from the University of Arizona in Tucson in 1969, Susan Leigh served as a Lieutenant in the U.S. Army Nurse Corps. Seven months after completing a tour of duty in the Mekong Delta in South Vietnam, she was diagnosed with Hodgkin lymphoma and treated with some of the earliest forms of chemotherapy and radiation. This experience influenced her decision to enter the newly founded field of oncology nursing and began this phase of her career working as a research nurse in the new Department of Hematology/Oncology at the University of Arizona Medical Center.

For the past 35 years, Susan has focused her efforts on national advocacy work with special emphasis on the long-term and late effects of cancer treatment. Her most cherished involvement has been with the National Coalition for Cancer Survivorship (NCCS) as a founding member and past president. She has also been actively involved with many professional organizations, including the Oncology Nursing Society and the National Cancer Institute.

Susan also worked as a Survivorship consultant and educator with Arizona Oncology, a multi-site community practice in Tucson, until multiple treatment-related cardiac complications made it difficult to fulfill work obligations and accelerated her decision to retire.

In addition to surviving Hodgkin lymphoma (1972), she has also been treated for breast cancer (1991), bladder cancer (1995), and, more recently, targeted radiation therapy for early-stage lung cancer (2016). Also, since 2013 she has been dealing with multiple cardiac issues that are considered fallout from her original cancer treatments. Meanwhile, she continues to promote awareness about the challenges of surviving cancer, and advocates for survivorship care planning and continual, systematic follow-up of long-term survivors.

This past October, Susan was the successful recipient of a new aortic valve through the TAVR procedure (transcatheter aortic valve replacement). This has been a life-saving medical procedure for long-term cancer survivors who are ineligible for open heart surgery.

Dr. Larissa Nekhlyudov is a Professor of Medicine at Harvard Medical School and is a practicing internist at the Brigham & Women’s Hospital in Boston, Massachusetts.  She is Clinical Director, Internal Medicine for Cancer Survivors at the Dana-Farber Cancer Institute where she offers clinical care for long-term survivors of childhood and adult cancers. Dr. Nekhlyudov is particularly interested in improving the care of cancer survivors and the interplay between primary and oncology care.  She has been at the forefront of the field of cancer survivorship, nationally and internationally, by leading and participating in the development of survivorship care policies and clinical guidelines, educational programs, and research. Throughout her career, Dr. Nekhlyudov has been committed to educating and empowering cancer survivors and their caregivers.

Dr. Michael D. Stubblefield is the Medical Director for Cancer Rehabilitation at Kessler Institute for Rehabilitation, National Medical Director for Select Medical’s ReVital Cancer Rehabilitation Program and National Medical Director for Complex Medical Rehabilitation for Select Medical’s Inpatient Rehabilitation Hospital Division. He is the former Chief of Cancer Rehabilitation at Memorial Sloan-Kettering Cancer Center. He is a Clinical Professor in the Department of Physical Medicine and Rehabilitation at the Rutgers New Jersey Medical School. He is board certified in Physical Medicine and Rehabilitation (PM&R), Internal Medicine, and Electrodiagnostic Medicine. His primary clinical expertise is in the identification, evaluation, and rehabilitation of neuromuscular, musculoskeletal, pain, and functional disorders resulting from cancer and its treatment, particularly those caused by radiation and neurotoxic chemotherapy.

Dr. Stubblefield is an accomplished researcher who has published extensively, not only in the rehabilitation literature, but in oncology, pain management, palliative care, neurophysiology, and other journals. He has authored numerous review articles and book chapters in the field of cancer rehabilitation and is the editor of Cancer Rehabilitation: Principles and Practice, the only comprehensive textbook in this emerging field now in its second edition. Dr. Stubblefield is a fierce advocate for the development of cancer rehabilitation and survivorship programs and champions their role in restoring function and quality of life to cancer patients.